Evoke (LON:EVOK - Get Free Report) had its price target lifted by stock analysts at Berenberg Bank from GBX 90 ($1.22) to GBX 95 ($1.29) in a report released on Tuesday, MarketBeat reports. The firm currently has a "buy" rating on the stock. Berenberg Bank's target price suggests a potential upside of 38.89% from the company's previous close.
Separately, JPMorgan Chase & Co. upped their target price on shares of Evoke from GBX 77 ($1.05) to GBX 80 ($1.09) and gave the stock a "neutral" rating in a research note on Thursday, July 10th.
Read Our Latest Research Report on EVOK
Evoke Stock Performance
LON EVOK traded down GBX 2.10 ($0.03) on Tuesday, reaching GBX 68.40 ($0.93). The company had a trading volume of 2,916,385 shares, compared to its average volume of 2,106,467. The firm has a market capitalization of £305.05 million, a price-to-earnings ratio of -1.71 and a beta of 0.84. Evoke has a 1-year low of GBX 36.70 ($0.50) and a 1-year high of GBX 77.80 ($1.06). The company's fifty day moving average is GBX 59 and its 200-day moving average is GBX 60.12.
Insider Transactions at Evoke
In related news, insider Per Widerström bought 68,958 shares of the stock in a transaction that occurred on Friday, May 23rd. The shares were acquired at an average price of GBX 54 ($0.73) per share, with a total value of £37,237.32 ($50,594.18). Also, insider Sean Wilkins bought 31,659 shares of the stock in a transaction that occurred on Friday, May 23rd. The stock was bought at an average cost of GBX 54 ($0.73) per share, for a total transaction of £17,095.86 ($23,228.07). In the last ninety days, insiders purchased 202,269 shares of company stock worth $10,515,918. 27.00% of the stock is owned by company insiders.
About Evoke
(
Get Free Report)
Recommended Stories
Before you consider Evoke, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Evoke wasn't on the list.
While Evoke currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.